IS6302A - Natríum-vetnis skipta gerð 1 lata kristallar - Google Patents

Natríum-vetnis skipta gerð 1 lata kristallar

Info

Publication number: IS6302A
Authority: IS; Iceland
Prior art keywords: latent; crystals; sodium; hydrogen replaces; replaces type
Prior art date: 1999-10-29

Application number

IS6302A

Other languages

English (en)

Inventor

Robinson Brostrom Lyle

Joseph Connolly Terrence

Jane Li Zheng

Lee Orrill Susan

Kiritkumar Shah Bharat

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-29

Filing date

2002-03-15

Publication date

2002-03-15

2002-03-15 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2002-03-15 Publication of IS6302A publication Critical patent/IS6302A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Neurology (AREA)
Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Treatment Of Water By Ion Exchange (AREA)

IS6302A 1999-10-29 2002-03-15 Natríum-vetnis skipta gerð 1 lata kristallar IS6302A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16237499P	1999-10-29	1999-10-29
PCT/IB2000/001460 WO2001030759A2 (en)	1999-10-29	2000-10-09	Sodium-hydrogen exchanger type 1 inhibitor crystals

Publications (1)

Publication Number	Publication Date
IS6302A true IS6302A (is)	2002-03-15

Family

ID=22585355

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6302A IS6302A (is)	1999-10-29	2002-03-15	Natríum-vetnis skipta gerð 1 lata kristallar

Country Status (44)

Country	Link
EP (1)	EP1224179B1 (is)
JP (1)	JP2003512455A (is)
KR (1)	KR100464526B1 (is)
CN (2)	CN1636991A (is)
AP (1)	AP2002002493A0 (is)
AR (1)	AR029402A1 (is)
AT (1)	ATE271047T1 (is)
AU (1)	AU778573B2 (is)
BG (1)	BG106729A (is)
BR (1)	BR0015275A (is)
CA (1)	CA2389020A1 (is)
CO (1)	CO5271714A1 (is)
CZ (1)	CZ20021332A3 (is)
DE (1)	DE60012208T2 (is)
DK (1)	DK1224179T3 (is)
DZ (1)	DZ3463A1 (is)
EA (1)	EA004937B1 (is)
EE (1)	EE200200227A (is)
ES (1)	ES2222923T3 (is)
GE (1)	GEP20043222B (is)
GT (1)	GT200000180A (is)
HK (1)	HK1048472B (is)
HR (1)	HRP20020366B1 (is)
HU (1)	HUP0204009A3 (is)
IL (1)	IL148581A0 (is)
IS (1)	IS6302A (is)
MA (1)	MA26840A1 (is)
MX (1)	MXPA02004358A (is)
NO (1)	NO20021821D0 (is)
NZ (1)	NZ517738A (is)
OA (1)	OA12080A (is)
PA (1)	PA8505501A1 (is)
PE (1)	PE20010764A1 (is)
PL (1)	PL354869A1 (is)
PT (1)	PT1224179E (is)
SI (1)	SI1224179T1 (is)
SK (1)	SK5312002A3 (is)
SV (1)	SV2002000209A (is)
TN (1)	TNSN00210A1 (is)
TR (1)	TR200201167T2 (is)
UA (1)	UA72002C2 (is)
WO (1)	WO2001030759A2 (is)
YU (1)	YU31502A (is)
ZA (1)	ZA200203295B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6441176B1 (en)	1999-10-29	2002-08-27	Pfizer Inc.	Method for preparing sodium-hydrogen exchanger type 1 inhibitor
CZ20032017A3 (cs) *	2001-01-31	2004-05-12	Pfizeráproductsáinc	Ethanoláty inhibitoru sodík@vodík měniče typu �Ź způsob jejich přípravyŹ jejich použití a farmaceutický prostředekŹ který je obsahuje
CA2472342A1 (en) *	2002-01-30	2003-08-07	Pfizer Products Inc.	Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
BR0309707A (pt) *	2002-05-02	2005-02-09	Pfizer Prod Inc	Tratamento de diabetes e complicações diabéticas com inibidores nhe-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU739403B2 (en) *	1998-02-27	2001-10-11	Pfizer Products Inc.	N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

2000
- 2000-09-10 UA UA2002043503A patent/UA72002C2/uk unknown
- 2000-10-09 OA OA1200200128A patent/OA12080A/en unknown
- 2000-10-09 SI SI200030449T patent/SI1224179T1/xx unknown
- 2000-10-09 PT PT00962776T patent/PT1224179E/pt unknown
- 2000-10-09 DE DE60012208T patent/DE60012208T2/de not_active Expired - Fee Related
- 2000-10-09 HU HU0204009A patent/HUP0204009A3/hu unknown
- 2000-10-09 CN CNA200410094665XA patent/CN1636991A/zh active Pending
- 2000-10-09 EA EA200200416A patent/EA004937B1/ru not_active IP Right Cessation
- 2000-10-09 CZ CZ20021332A patent/CZ20021332A3/cs unknown
- 2000-10-09 ES ES00962776T patent/ES2222923T3/es not_active Expired - Lifetime
- 2000-10-09 IL IL14858100A patent/IL148581A0/xx unknown
- 2000-10-09 KR KR10-2002-7005366A patent/KR100464526B1/ko not_active Expired - Fee Related
- 2000-10-09 NZ NZ517738A patent/NZ517738A/en unknown
- 2000-10-09 GE GEAP20006430A patent/GEP20043222B/en unknown
- 2000-10-09 TR TR2002/01167T patent/TR200201167T2/xx unknown
- 2000-10-09 MX MXPA02004358A patent/MXPA02004358A/es active IP Right Grant
- 2000-10-09 EE EEP200200227A patent/EE200200227A/xx unknown
- 2000-10-09 CN CNB008146748A patent/CN1205205C/zh not_active Expired - Fee Related
- 2000-10-09 HK HK03100504.6A patent/HK1048472B/zh not_active IP Right Cessation
- 2000-10-09 EP EP00962776A patent/EP1224179B1/en not_active Expired - Lifetime
- 2000-10-09 AU AU74415/00A patent/AU778573B2/en not_active Ceased
- 2000-10-09 WO PCT/IB2000/001460 patent/WO2001030759A2/en not_active Ceased
- 2000-10-09 AT AT00962776T patent/ATE271047T1/de not_active IP Right Cessation
- 2000-10-09 PL PL00354869A patent/PL354869A1/xx not_active Application Discontinuation
- 2000-10-09 DZ DZ003463A patent/DZ3463A1/fr active
- 2000-10-09 JP JP2001533113A patent/JP2003512455A/ja active Pending
- 2000-10-09 DK DK00962776T patent/DK1224179T3/da active
- 2000-10-09 HR HR20020366A patent/HRP20020366B1/xx not_active IP Right Cessation
- 2000-10-09 CA CA002389020A patent/CA2389020A1/en not_active Abandoned
- 2000-10-09 BR BR0015275-7A patent/BR0015275A/pt not_active IP Right Cessation
- 2000-10-09 AP APAP/P/2002/002493A patent/AP2002002493A0/en unknown
- 2000-10-09 YU YU31502A patent/YU31502A/sh unknown
- 2000-10-09 SK SK531-2002A patent/SK5312002A3/sk unknown
- 2000-10-18 GT GT200000180A patent/GT200000180A/es unknown
- 2000-10-20 PA PA20008505501A patent/PA8505501A1/es unknown
- 2000-10-25 CO CO00081375A patent/CO5271714A1/es not_active Application Discontinuation
- 2000-10-26 PE PE2000001145A patent/PE20010764A1/es not_active Application Discontinuation
- 2000-10-27 AR ARP000105700A patent/AR029402A1/es unknown
- 2000-10-27 TN TNTNSN00210A patent/TNSN00210A1/fr unknown
- 2000-10-27 SV SV2000000209A patent/SV2002000209A/es unknown
2002
- 2002-03-15 IS IS6302A patent/IS6302A/is unknown
- 2002-04-18 NO NO20021821A patent/NO20021821D0/no not_active Application Discontinuation
- 2002-04-22 MA MA26615A patent/MA26840A1/fr unknown
- 2002-04-25 ZA ZA200203295A patent/ZA200203295B/xx unknown
- 2002-05-20 BG BG106729A patent/BG106729A/bg unknown

Also Published As

Publication number	Publication date
WO2001030759A3 (en)	2001-09-13
CZ20021332A3 (cs)	2002-10-16
ES2222923T3 (es)	2005-02-16
AU778573B2 (en)	2004-12-09
NZ517738A (en)	2005-06-24
ZA200203295B (en)	2003-06-25
IL148581A0 (en)	2002-09-12
JP2003512455A (ja)	2003-04-02
HUP0204009A2 (hu)	2003-03-28
HRP20020366A2 (en)	2004-02-29
ATE271047T1 (de)	2004-07-15
EA200200416A1 (ru)	2002-10-31
KR20020040918A (ko)	2002-05-30
CO5271714A1 (es)	2003-04-30
BG106729A (bg)	2002-12-29
AP2002002493A0 (en)	2002-06-30
CN1384829A (zh)	2002-12-11
SV2002000209A (es)	2002-07-16
DK1224179T3 (da)	2004-10-25
DZ3463A1 (fr)	2001-05-03
NO20021821L (no)	2002-04-18
DE60012208D1 (de)	2004-08-19
PT1224179E (pt)	2004-10-29
EE200200227A (et)	2003-06-16
EP1224179B1 (en)	2004-07-14
HK1048472A1 (en)	2003-04-04
TR200201167T2 (tr)	2002-08-21
GEP20043222B (en)	2004-04-26
HRP20020366B1 (en)	2005-04-30
OA12080A (en)	2003-08-25
UA72002C2 (en)	2005-01-17
TNSN00210A1 (fr)	2005-11-10
WO2001030759A2 (en)	2001-05-03
BR0015275A (pt)	2002-07-16
PA8505501A1 (es)	2003-09-05
AU7441500A (en)	2001-05-08
CN1205205C (zh)	2005-06-08
SK5312002A3 (en)	2003-01-09
PE20010764A1 (es)	2001-07-23
CN1636991A (zh)	2005-07-13
CA2389020A1 (en)	2001-05-03
DE60012208T2 (de)	2005-07-21
EA004937B1 (ru)	2004-10-28
EP1224179A2 (en)	2002-07-24
GT200000180A (es)	2002-04-11
YU31502A (sh)	2004-12-31
MXPA02004358A (es)	2002-11-07
HK1048472B (zh)	2005-09-16
HUP0204009A3 (en)	2004-07-28
SI1224179T1 (en)	2004-10-31
MA26840A1 (fr)	2004-12-20
PL354869A1 (en)	2004-03-08
AR029402A1 (es)	2003-06-25
NO20021821D0 (no)	2002-04-18
KR100464526B1 (ko)	2005-01-03

Publication	Publication Date	Title
IS2027B (is)	2005-08-15	Ný spíróasabísýklísk heterósýklísk efnasambönd
LTPA2009006I1 (lt)	2022-03-10	Trombopoetino junginiai
ATE229954T1 (de)	2003-01-15	Betacarbolinverbindungen
ID28266A (id)	2001-05-10	Senyawa-senyawa amidin
DK1137635T3 (da)	2006-02-13	N-substituerede 2-cyanopyrrolidiner
NO20011745L (no)	2001-06-06	Forbindelser
FI4209U1 (fi)	1999-11-10	Uusia yhdisteitä
DE69915289D1 (de)	2004-04-08	Kühlvorrichtung
ID24221A (id)	2000-07-13	Tempat patrum
NO20005006L (no)	2000-10-04	Kalsilytiske forbindelser
DE59910800D1 (de)	2004-11-18	Kühler
DK1216284T3 (da)	2006-04-03	R 22-erstatningskölemiddel
EP1067925A4 (en)	2003-04-16	ANTIDIABETIC CONNECTIONS
NO20006662L (no)	2000-12-27	Fluorfenylresin-forbindelser
DE59905452D1 (de)	2003-06-18	Mikroskop
DE69928527D1 (de)	2005-12-29	Farbtoner
IS6302A (is)	2002-03-15	Natríum-vetnis skipta gerð 1 lata kristallar
DE69926606D1 (de)	2005-09-15	Plazentaprotein 13
ATA149998A (de)	2002-03-15	Ladenbeschlag
PT9470T (pt)	1999-11-30	Visir
LV12234A (lv)	1999-03-20	Tramplina slepes
FI980204A7 (fi)	1999-07-30	Tähystähtäin
IDP000021799A (id)	1999-07-29	Senyawa-senyawa pirolum tersubstitusi
IDP000021790A (id)	1999-07-29	Senyawa-senyawa pirolum tersubstitusi
SE9800626D0 (sv)	1998-02-27	Compounds